Mirati Therapeutics, Inc. logo

Mirati Therapeutics, Inc.

Mirati Therapeutics, Inc., a clinical-stage oncology company, develops targeted therapeutics to address the genetic, epigenetic, and immunological promoters of cancer.

[stock_market_widget type=”leaderboard” template=”color-frame” color=”yellow” assets=”MRTX” api=”yf” style=”font-size: 15px”]

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttps://www.mirati.com
Founded2013
Disease Focus
Development StageClinical
STOCK CODENASDAQ: MRTX
Address
9393 Towne Centre Drive Suite 200, CA 92121
San Diego
United States
Email
Contact Number
+1 858-332-3410

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/mirati-therapeutics-inc” connections=”true” suffix=””]